Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Non-Current Deferred Tax Liability (2017 - 2019)

Altimmune (ALT) has disclosed Non-Current Deferred Tax Liability for 3 consecutive years, with $58500.0 as the latest value for Q2 2019.

  • On a quarterly basis, Non-Current Deferred Tax Liability fell 98.68% to $58500.0 in Q2 2019 year-over-year; TTM through Jun 2019 was $58500.0, a 98.68% decrease, with the full-year FY2018 number at $58500.0, down 99.01% from a year prior.
  • Non-Current Deferred Tax Liability was $58500.0 for Q2 2019 at Altimmune, roughly flat from $58500.0 in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $8.5 million in Q2 2017 to a low of $58500.0 in Q4 2018.
  • A 3-year average of $4.0 million and a median of $4.4 million in 2018 define the central range for Non-Current Deferred Tax Liability.
  • Biggest YoY gain for Non-Current Deferred Tax Liability was 48.14% in 2018; the steepest drop was 99.01% in 2018.
  • Altimmune's Non-Current Deferred Tax Liability stood at $5.9 million in 2017, then crashed by 99.01% to $58500.0 in 2018, then changed by 0.0% to $58500.0 in 2019.
  • Per Business Quant, the three most recent readings for ALT's Non-Current Deferred Tax Liability are $58500.0 (Q2 2019), $58500.0 (Q1 2019), and $58500.0 (Q4 2018).